LinkedIn

The worldwide generics industry has seen strong growth in recent times as the demand for affordable treatment has increased worldwide. In addition to this, numerous branded-drug patent expirations, the prospect of generic biotechnology drugs and a favourable regulatory environment is providing a huge opportunity for the sector to expand further. Join us for SMi's 13th annual Generics, Super-Generics and Patent Strategies and discover the future of the generics market. Hear experts in the field discuss the latest patent strategies, regulatory updates and growth strategies that will be key to the future of the industry. Key topics: * Examine the legal framework and litigation mechanics in both the EU and US * Latest legislative and regulatory updates in generics and biosimilars * Identify key growth areas and methods to take advantage of these * M&A activities and their implications * New business models * Emerging markets * R&D in generics